Navigation Links
Australia's Leading Juice Company Launches Juice Blend with Martek's life'sDHA(TM)
Date:3/13/2008

COLUMBIA, Md., March 13 /PRNewswire-FirstCall/ -- Martek Biosciences (Nasdaq: MATK) announced today that life'sDHA(TM), its patented, vegetarian form of DHA-omega 3 for brain, eye and heart health, is available in the new Berri Australian Fresh Omega-3 for Heart & Mind juice-blend from National Foods, Australia's No. 1 juice company. National Foods is the largest citrus and fruit processor in Australia, packaging approximately 50 percent of all fruit juice beverages sold in the country. Sold in major retailers across Australia and available in extra pulpy orange flavor with DHA omega-3 for heart and mind, Berri Australian Fresh Omega-3 for Heart & Mind juice-blend provides 50mg per serving of life'sDHA.

"Berri Australian Fresh Omega-3 for Heart & Mind juice-blend marks our second product with National Foods, joining Pura(R) Kids with life'sDHA," said Joe Buron, vice president of marketing and sales for Martek. "We're pleased to be working with one of Australia's largest food companies through their Pura and Berri brands to offer a safe, contaminant-free alternative for Australian consumers to get the important health benefits of DHA."

DHA (docosahexaenoic acid) omega-3 is a long-chain omega-3 fatty acid that serves as a primary building block for the brain and the eyes and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages, from infants to aging adults, benefit from an adequate supply of DHA omega-3 in their diets. Several recent scientific reviews have noted the importance of DHA omega-3 in proper brain and eye development and function, and there are clinical studies underway to evaluate its role in decreasing the prevalence of certain neurological disorders.

Fish are often thought to be the only source of DHA omega-3. However, life'sDHA offers a safe, vegetarian form of DHA that contains no oceanic pollutants and toxins. Fish are rich sources of DHA because they eat microalgae; life'sDHA is derived from microalgae and produced in an FDA- inspected facility from start to finish using a sustainable source that does not deplete ocean resources. life'sDHA is found in numerous foods, beverages and supplements for people of all ages. It is also the only source of DHA used in U.S. infant formula and is available in more than 90 percent of the formulas on the U.S. market.

In Australia, Martek is represented by distributor VILCO PTY LTD, Australia, to maximize the availability of life'sDHA in food and beverages.

National Foods is a wholly owned subsidiary of Kirin Holdings Company, Limited -- Incorporated in Japan. It is one of Australia's largest food companies, with core activities in milk, fresh dairy foods, juice and specialty cheese. National Foods' Pura Milk is the country's number one milk brand. Additionally, National Foods is the largest citrus and fruit processor in Australia, packaging approximately 50 percent of all fruit juice beverages sold nationally. For more information on National Foods, visit http://www.natfoods.com.au .

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA, a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com. For a complete list of product, visit http://www.lifesdha.com.

Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2007 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.

Contact:

Cassie France-Kelly

Public Relations

Martek Biosciences

(443) 542-2116

media@martek.com

Kyle Stults

Investor Relations

Martek Biosciences

(410) 740-0081

investors@martek.com


'/>"/>
SOURCE Martek Biosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers develop a method to select eggs with the best chance of leading to successful pregnancy
2. Leading researchers honored for progress in cancer prevention, detection and treatment
3. Following School Suicide, National Childrens Charity Issues Tips and Free Resources to Help Prevent 3rd Leading Cause of Death Among Youth
4. Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel
5. Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution
6. Leading Health Groups Strongly Support the Minnesota Department of Healths Efforts to Enforce Freedom to Breathe Act
7. Home Oxygen Community Applauds Senator Pat Roberts for Leading Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
8. Home Oxygen Community Applauds Senator Blanche Lincoln for Leading Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
9. Leading Natural Cosmetics Company Supports Breast Cancer Survivors
10. Scientists uncover further steps leading to celiac disease
11. IDC X-Series DR system selected for use in leading edge RSA clinical trial application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology: